EDITORIAL
Published on 23 Feb 2022
Editorial: Resistance to Medical Therapy in Pituitary Tumors
doi 10.3389/fendo.2022.861230
- 1,073 views
- 1 citation
- Frontiers in Endocrinology
- Pituitary Endocrinology
- Research Topics
- Resistance to Medical Therapy in Pituitary Tumors
Resistance to Medical Therapy in Pituitary Tumors
8,978
Total downloads
28k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
MINI REVIEW
Published on 12 Jan 2022
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms
doi 10.3389/fendo.2021.791633
- 4,634 views
- 8 citations
ORIGINAL RESEARCH
Published on 07 May 2021
Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective
doi 10.3389/fendo.2021.677919
- 2,984 views
- 18 citations
REVIEW
Published on 16 Mar 2021
Pasireotide in the Personalized Treatment of Acromegaly
doi 10.3389/fendo.2021.648411
- 6,928 views
- 31 citations
MINI REVIEW
Published on 15 Mar 2021
Epithelial–Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly
doi 10.3389/fendo.2021.646210
- 2,378 views
- 18 citations
ORIGINAL RESEARCH
Published on 16 Feb 2021
A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation
doi 10.3389/fendo.2020.611752
- 2,323 views
- 9 citations
ORIGINAL RESEARCH
Published on 04 Aug 2020
Clinical, Hormonal, and Neuroradiological Characteristics and Therapeutic Outcomes of Prolactinomas in Children and Adolescents at a Single Center
doi 10.3389/fendo.2020.00527
- 4,156 views
- 10 citations
Published in
Frontiers in Endocrinology
- Pituitary Endocrinology
Impact
- 28kTopic views
- 19kArticle views
- 8,978Article downloads